Literature DB >> 31475476

Physical capacity outcomes in patients with severe obesity after 12 months of physician-led multidisciplinary team care: A case series from a public hospital clinical obesity service.

Evan Atlantis1,2, Kiri Langford3,4, Milan Piya3,4, Vincent Ho3,4, Kathryn Skelsey3,4, Lachlan Rickards3, Suzanne Edwards5, Nic Kormas3,6.   

Abstract

Impaired physical capacity is common in people with severe levels of obesity. We aimed to investigate changes in physical capacity outcomes in patients with severe obesity following 12 months of physician-led multidisciplinary care from a "real world" Australian public hospital setting using a case series study design. We extracted data from medical records for all of the eligible patients referred to our clinical obesity service from 2010 to 2015 (69 of 239). We found significant (P < .05) pre-test/post-test (mean ± SD) improvements in the 6-minute walk test (6MWT) (339 ± 120 to 417 ± 112 m); 30-second sit-to-stand test (11 ± 4 to 15 ± 6 counts) and sit-and-reach test (-12 ± 13 to -8 ± 15 cm). Using linear mixed-effects models adjusting for repeated measurements over time (baseline vs 12 months) and testing for potential predictors, we found: mean 6MWT was associated with 12-month time period (56 m), body mass index (BMI, -3 m), no walking aid over 12 months (106 m) and no opioid analgesics (75 m); mean sit-to-stand was associated with 12-month time period (3 counts), age at referral (-0.2 counts), BMI (-0.2 counts), and diabetes (3 counts); and mean sit-and-reach was associated with 12-month time period (5 cm), female gender (5 cm) and total medications (-0.9 cm). Using causal mediation analysis, our results show that total exercise classes partially mediates change in walking capacity among those with cardiovascular disease. Our study shows that significant and clinically important improvements in physical capacity outcomes in patients with severe obesity can be achieved following 12 months of intensive specialist obesity services, such as ours.
© 2019 World Obesity Federation.

Entities:  

Keywords:  hospital outpatient clinics; obesity; specialist weight management; weight loss

Mesh:

Year:  2019        PMID: 31475476     DOI: 10.1111/cob.12337

Source DB:  PubMed          Journal:  Clin Obes        ISSN: 1758-8103


  5 in total

1.  Improvement in Eating Disorder Risk and Psychological Health in People with Class 3 Obesity: Effects of a Multidisciplinary Weight Management Program.

Authors:  Milan K Piya; Ritesh Chimoriya; William Yu; Kathy Grudzinskas; Kyaw Phone Myint; Kathryn Skelsey; Nic Kormas; Phillipa Hay
Journal:  Nutrients       Date:  2021-04-23       Impact factor: 5.717

2.  Clinical Use of the Edmonton Obesity Staging System for the Assessment of Weight Management Outcomes in People with Class 3 Obesity.

Authors:  Raymond Kodsi; Ritesh Chimoriya; David Medveczky; Kathy Grudzinskas; Evan Atlantis; Abd A Tahrani; Nic Kormas; Milan K Piya
Journal:  Nutrients       Date:  2022-02-24       Impact factor: 5.717

3.  Class 3 Obesity in a Multidisciplinary Metabolic Weight Management Program: The Effect of Preexisting Type 2 Diabetes on 6-Month Weight Loss.

Authors:  David M Medveczky; Raymond Kodsi; Kathryn Skelsey; Kathy Grudzinskas; Flavia Bueno; Vincent Ho; Nic Kormas; Milan K Piya
Journal:  J Diabetes Res       Date:  2020-08-01       Impact factor: 4.011

4.  A predictive model for non-completion of an intensive specialist obesity service in a public hospital: a case-control study.

Authors:  Evan Atlantis; Fang Lin; Sulak Anandabaskaran; Paul Fahey; Nic Kormas
Journal:  BMC Health Serv Res       Date:  2019-10-24       Impact factor: 2.655

5.  Impact of a Mobile Telerehabilitation Solution on Metabolic Health Outcomes and Rehabilitation Adherence in Patients With Obesity: Randomized Controlled Trial.

Authors:  François Bughin; Gaspard Bui; Bronia Ayoub; Leo Blervaque; Didier Saey; Antoine Avignon; Jean Frédéric Brun; Nicolas Molinari; Pascal Pomies; Jacques Mercier; Fares Gouzi; Maurice Hayot
Journal:  JMIR Mhealth Uhealth       Date:  2021-12-06       Impact factor: 4.773

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.